Near-infrared fluorescent nerve contrast agents and methods of use thereof
US-2016347727-A1 · Dec 1, 2016 · US
US9556134B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9556134-B2 |
| Application number | US-201314894660-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 28, 2013 |
| Priority date | May 28, 2013 |
| Publication date | Jan 31, 2017 |
| Grant date | Jan 31, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed are antioxidative natural compounds, their salts, chelates and cleavage derivatives that exhibit a superior combination of properties. The compounds can be used for a variety of purposes, including the stabilization of polymers. The compounds can be prepared by substantially cleaving a humic acid of formula I followed by esterification to provide at least one antioxidant compounds of formula V, formula VI, formula VII, formula VIII, salts thereof, or chelates thereof.
Opening claim text (preview).
What is claimed is: 1. A stabilizing compound comprising a compound of formula V: wherein R 11 is —N(R 111 )(R 112 ), wherein R 111 is C-acetamido or substituted C-acetamido; R 112 is hydrogen, —(C 1 -C 20 )alkyl, substituted —(C 1 -C 20 )alkyl, —(C═O)—(C 3 -C 19 )alkyl, or substituted -(C═O)—(C 3 -C 19 )alkyl; R 12 , R 141 , R 142 , R 143 , and R 144 are independently hydrogen, —(C 1 -C 20 )alkyl, or substituted —(C 1 -C 20 )alkyl; R 13 is hydrogen, —(C 1 -C 20 )alkyl, substituted —(C 1 -C 20 )alkyl, —(C═O)—(C 3 -C 19 )alkyl, or substituted —(C═O)—(C 3 -C 19 )alkyl; R 16 is a hydrogen, glucuronate or substituted glucuronate; R 151 , R 152 , R 153 , R 154 , R 155 , and R 156 are independently hydrogen, —(C═O)—(C 3 -C 19 )alkyl, or substituted —(C═O)—(C 3 -C 19 )alkyl, wherein at least one of R 141 , R 142 , R 143 , R 144 , R 151 , R 152 , R 153 , R 154 , R 155 , and R 156 is not hydrogen; a salt, chelate, or combination thereof. 2. The compound of claim 1 , wherein the compound is a salt thereof. 3. The compound of claim 1 , wherein R 141 , R 142 , R 143 , and R 144 are independently hydrogen or —(C 4 -C 20 )alkyl. 4. The compound of claim 1 , wherein R 151 , R 152 , R 153 , R 154 , R 155 , and R 156 are independently hydrogen or —(C═O)—(C 3 -C 19 )alkyl. 5. The compound of claim 1 , wherein the compound is a lithium salt, sodium salt, ammonium salt, potassium salt, calcium salt, barium salt, magnesium salt, manganese salt, zinc salt, aluminum salt, iron salt, or a combination thereof. 6. The compound of claim 1 , wherein the compound is a polyvalent cation chelate. 7. The compound of claim 1 , wherein the compound is a calcium chelate, magnesium chelate, iron chelate, or zinc chelate or combination thereof. 8. A method of preparing a polymer stabilizing mixture of compounds, the method comprising: substantially hydrolyzing a humic acid to form a mixture of compounds according to formula V a salt or chelate thereof: wherein: R 11 is —N(R 111 )(R 112 ), wherein R 111 is C-acetamido or substituted C-acetamido; R 112 is hydrogen, —(C 1 -C 20 )alkyl, substituted —(C 1 —C 20 )alkyl, —(C═O)—(C 3 -C 19 alkyl, or substituted —(C═O)—(C 3 -C 19 )alkyl; R 12 , R 141 , R 142 , R 143 and R 144 are independently hydrogen, -(C 4 —C 20 )alkyl, or substituted —(C 4 -C 20 alkyl; R 13 is hydrogen, —(C 1 -C 20 alkyl, substituted —(C 1 -C 20 )alkyl, —(C═O)—(C 3 —C 19 )alkyl, or substituted —(C═O)—(C 3 -C 19 )alkyl; R 16 is hydrogen, glucuronate, or substituted glucuronate; R 151 , R 152 , R 153 , R 154 , R 155 , and R 156 are independently hydrogen, —(C═O)—(C 3 -C 19 )alkyl, or substituted —(C═O)—(C 3 -C 19 )alkyl; R 141 , R 142 , R 143 , R 144 , R 151 , R 152 , R 153 , R 154 , R 155 , and R 156 are hydrogen; and esterifying at least one functional group of the mixture of compounds to give a polymer stabilizing mixture of compounds. 9. The method of claim 8 , further comprising forming a chelate of the compound of the polymer stabilizing mixture with a calcium cation, magnesium cation, zinc cation, iron cation, or combinations thereof. 10. The method of claim 8 , further comprising forming a salt of the compound of the polymer stabilizing mixture to form a lithium salt, sodium salt, ammonium salt, potassium salt, calcium salt, barium salt, magnesium salt, manganese salt, zinc salt, aluminum salt, iron salt, or a combination thereof. 11. The method of claim 8 , further comprising purifying the compound of the polymer stabilizing mixture. 12. The method of claim 8 , further comprising isolating the compound of formula V wherein at least one of R 141 , R 142 , R 143 , R 144 , R 151 , R 152 , R 153 , R 154 , R 155 , and R 156 is not hydrogen; at least one of R 21 , R 22 , R 23 , R 24 , R 25 , R 26 , and R 27 is not hydrogen; at least one of R 31 , R 32 , R 33 , R 34 , R 35 , and R 36 is not hydrogen; and at least one of R 41 , R 42 , R 43 , and R 44 is not hydrogen. 13. The method of claim 8 , wherein the humic acid comprises at least one compound of formula I: salt, or chelate thereof, wherein R 11 is —N(R 111 )(R 112 ), wherein R 111 is C-acetamido or substituted C-acetamido; R 112 is hydrogen, —(C 1 —C 20 )alkyl, substituted —(C 1 -C 20 )alkyl, —(C═O)—(C 3 -C 19 )alkyl, or substituted —(C═O)—(C 3 —C 19 )alkyl; R 12 is hydrogen, —(C 1 -C 20 )alkyl, or substituted —(C 1 -C 20 )alkyl; R 13 is hydrogen, —(C 1 -C 20 )alkyl, substituted —(C 1 -C 20 )alkyl, —(C═O)—(C 3 -C 19 )alkyl, or substituted —(C═O)—(C 3 -C 19 )alkyl; and R 16 is a hydrogen, glucuronate or substituted glucuronate. 14. The method of claim 8 , wherein the hydrolyzing comprises hydrolyzing in the presence of an alkaline solution. 15. The method of claim 14 , wherein the alkaline solution is aqueous lithium hydroxide, aqueous sodium hydroxide, aqueous potassium hydroxide, or combination thereof. 16. The method of claim 8 , wherein the hydrolyzing comprises hydrolyzing at a pH of 8.5-13.
containing heterocyclic ring with at least one nitrogen atom as ring member · CPC title
containing oxygen · CPC title
Six-membered rings · CPC title
Five-membered rings · CPC title
ortho- or peri-condensed with carbocyclic rings or ring systems · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.